Tumor-cell-induced platelet activation (TCIPA) strictly depends on thrombin formation [27,28], raising the question whether thrombin, accelerated in formation by the increased TF activity of EXT1 kd cells, also contributes to tumor cell resistance in MV3EXT1kd cells. The gene discussed is EXT1; the disease is neoplasm.